Defense response to tumor cell

pathway activity — cross-omics
GO:0002357Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Defense response to tumor cell pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are NPTX2, RASD2, and RPGRIP1L, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Defense response to tumor cell activity versus NPTX2 in LSCC (Pearson r = -0.31).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCNPTX2 →-1.192-0.599<.001.00334
LSCCRASD2 →-0.732-0.515.006.00133
LSCCRPGRIP1L →-0.365-0.757.007<.00133
LSCCTMEM169 →-0.325-0.537.005.00833
LUADHOPX →+1.078+0.532.003.00533
LUADKAAG1 →-0.172-0.636.006<.00124
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002357 vs NPTX2 — LSCC

Per-sample scatter of Defense response to tumor cell activity vs NPTX2 in LSCC.

Explore this scatter interactively →

Exploration